Liver Transplantation: Where Are We Now and Where Are We Going?

Поділитися
Вставка
  • Опубліковано 12 чер 2022
  • What’s new in the world of liver transplantation? We will discuss the rapidly changing epidemiology of liver transplant causes, the surprising news about transplant rates and long-term outcomes, and how to improve the likelihood of successful transplants. Danielle Brandman, associate professor and director of the UCSF Hepatology Fellowship Program, and Shareef Syed, assistant professor of surgery and director of the UCSF Abdominal Transplant Fellowship Program, will take us on a tour of the landscape of liver transplantation.
    Speakers:
    Danielle Brandman, MD, MAS, is an associate professor of medicine and a hepatologist, specializing in treating patients needing liver transplants. Her research interests include nonalcoholic fatty liver disease and post-transplant metabolic syndrome. She is also the director of the Hepatology Fellowship Program and chief of service of inpatient hepatology at UCSF.
    Shareef Syed, MBChB, MRCS, is an assistant professor of surgery and a general surgeon specializing in abdominal transplantation. Shareef is also associate director of the UCSF Surgical Skills Center and director of the UCSF Abdominal Transplant Fellowship Program.
    Note: Closed captions will be available within 48-72 hours after posting.
    Program
    Bob Wachter: Introduction
    00:02:35-00:24:57 - Danielle Brandman, MD, MAS (associate professor, Department of Medicine, Division of Gastroenterology at UCSF Health)
    00:25:02-00:39:16 - Shareef Syed, MBChB, MRCS (assistant professor, Department of Surgery, Division of Transplant Surgery at UCSF Health)
    00:39:23-00:46:02 - Danielle Brandman, MD, MAS (associate professor, Department of Medicine, Division of Gastroenterology at UCSF Health)
    00:46:27-00:58:41 - Q&A
    Bob Wachter: Closing
    See previous Medical Grand Rounds:
    • June 2: In Conversation with White House COVID-19 Response Coordinator Ashish Jha
    • In Conversation with W...
    • May 26: Immune Checkpoint Inhibitors: The Good, the Bad, and the Emerging Field of Cardio-Oncology
    • Immune Checkpoint Inhi...
    • May 19: Healthcare for the Underserved - What’s Roe Got to Do with It?
    • Healthcare for the Und...
    • May 12: Respiratory Health after Military Service in Southwest Asia and Afghanistan:
    Insights for Clinicians
    • Respiratory Health aft...
    See all UCSF Covid-19 grand rounds, which have been viewed over 3M times, here: medicine.ucsf.edu/covid-19-ne...

КОМЕНТАРІ • 2

  • @infectdiseaseepidemiology2599
    @infectdiseaseepidemiology2599 2 роки тому +3

    No comments? All I can say is that posting Grand Rounds is a great service globally. Here I am, an infectious disease epidemiologist at a certain major School of Public Health and School of Medicine about 550 miles north of you but south of the Canadian border, and UCSF Grand Rounds is the first place that I “go” for continuing education and new thinking on various topics of medical and public health thinking. Thus, a deep thanks to you, my colleagues. It is always worth an hour to watch Grand Rounds.

  • @alexandrurunceanu1735
    @alexandrurunceanu1735 Рік тому

    B+D, liver cirrhosis
    Can you make it for ?
    That's the satisfaction of life!'
    I'm asking for myself
    Would you"?